AYURCANN HOLDINGS CORP. Market Cap ($97.35K)
Market Cap & Net Worth: AYURCANN HOLDINGS CORP. (3ZQ0)
AYURCANN HOLDINGS CORP. market cap. AYURCANN HOLDINGS CORP. (F:3ZQ0) has a market capitalization of $97.35K (€83.27K) as of November 3, 2026. Listed on the F stock exchange, this Germany-based company holds position #31542 globally and #2811 in its home market, demonstrating a 0.00% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying AYURCANN HOLDINGS CORP.'s stock price €0.00 by its total outstanding shares 194703863 (194.70 Million). Also see AYURCANN HOLDINGS CORP. cash conversion from operations for how efficiently the company converts equity into cash flow.
AYURCANN HOLDINGS CORP. Market Cap History (2021–2026)
AYURCANN HOLDINGS CORP. market cap history from 2021 to 2026. Data shows change from $31.87 Million to $113.81K (-66.18% CAGR). Check AYURCANN HOLDINGS CORP. (3ZQ0) stock price for real-time trading data and today's change.
AYURCANN HOLDINGS CORP. Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how AYURCANN HOLDINGS CORP.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Explore AYURCANN HOLDINGS CORP. equity growth rate to track how rapidly the company is growing its equity base year over year.
Latest Price to Sales (P/S) Ratio
0.04x
AYURCANN HOLDINGS CORP.'s market cap is 0.04 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2022 | $3.98 Million | $9.39 Million | -$3.09 Million | 0.42x | N/A |
| 2023 | $2.28 Million | $12.49 Million | -$5.31 Million | 0.18x | N/A |
| 2024 | $5.35 Million | $25.16 Million | -$3.97 Million | 0.21x | N/A |
| 2025 | $1.25 Million | $31.11 Million | -$3.49 Million | 0.04x | N/A |
Competitor Companies of 3ZQ0 by Market Capitalization
Companies near AYURCANN HOLDINGS CORP. in the global market cap rankings as of November 3, 2026. Also see AYURCANN HOLDINGS CORP. balance sheet assets for a full breakdown of the balance sheet.
Key companies related to AYURCANN HOLDINGS CORP. by market ranking:
- Takeda Pharmaceutical Co Ltd ADR (NYSE:TAK): Ranked #516 globally with a market cap of $52.60 Billion USD.
- GALDERMA GROUP AG (NYSE:GALDY): Ranked #536 globally with a market cap of $50.42 Billion USD.
- Jiangsu Hengrui Medicine Co Ltd (SHG:600276): Ranked #591 globally with a market cap of $45.45 Billion USD ( CN¥310.59 Billion CNY).
- Takeda Pharmaceutical Company Limited (F:TKDA): Ranked #618 globally with a market cap of $43.60 Billion USD ( €37.29 Billion EUR).
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #516 | Takeda Pharmaceutical Co Ltd ADR | NYSE:TAK | $52.60 Billion | $16.65 |
| #536 | GALDERMA GROUP AG | NYSE:GALDY | $50.42 Billion | $46.55 |
| #591 | Jiangsu Hengrui Medicine Co Ltd | SHG:600276 | $45.45 Billion | CN¥48.69 |
| #618 | Takeda Pharmaceutical Company Limited | F:TKDA | $43.60 Billion | €18.50 |
Market Capitalization of AYURCANN HOLDINGS CORP. (2021–2026)
Market capitalization of AYURCANN HOLDINGS CORP. from 2021 to today. Between 2021 and today, AYURCANN HOLDINGS CORP.'s market cap moved from $31.87 Million to $ 113.81K, with a yearly change of -66.18%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | €113.81K | -90.91% |
| 2025 | €1.25 Million | -76.60% |
| 2024 | €5.35 Million | +135.00% |
| 2023 | €2.28 Million | -42.86% |
| 2022 | €3.98 Million | -87.50% |
| 2021 | €31.87 Million | -- |
End of Day Market Cap According to Different Sources
On Nov 3rd, 2026 the market cap of AYURCANN HOLDINGS CORP. was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $97.35K USD |
| MoneyControl | $97.35K USD |
| MarketWatch | $97.35K USD |
| marketcap.company | $97.35K USD |
| Reuters | $97.35K USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About AYURCANN HOLDINGS CORP.
Ayurcann Holdings Corp. provides post-harvest outsourcing solutions to licensed cannabis producers in Canada. The company offers extraction, processing, and co-manufacturing of pharma grade cannabis to produce various derivative cannabis products in the medical and recreational markets. It also manufactures and distributes cannabis products. The company sells product under the Fuego, H&S, and XPL… Read more